These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 17159223

  • 21. Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans.
    Shukla S, Yadav V, Mukhopadhyay G, Prasad R.
    Eukaryot Cell; 2011 Oct; 10(10):1357-66. PubMed ID: 21856931
    [Abstract] [Full Text] [Related]

  • 22. Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains.
    Dunkel N, Blass J, Rogers PD, Morschhäuser J.
    Mol Microbiol; 2008 Aug; 69(4):827-40. PubMed ID: 18577180
    [Abstract] [Full Text] [Related]

  • 23. PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans.
    Manoharlal R, Gorantala J, Sharma M, Sanglard D, Prasad R.
    Microbiology (Reading); 2010 Feb; 156(Pt 2):313-326. PubMed ID: 19910410
    [Abstract] [Full Text] [Related]

  • 24. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
    Smith WL, Edlind TD.
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3532-9. PubMed ID: 12384361
    [Abstract] [Full Text] [Related]

  • 25. Inducible and constitutive activation of two polymorphic promoter alleles of the Candida albicans multidrug efflux pump MDR1.
    Sasse C, Schillig R, Reimund A, Merk J, Morschhäuser J.
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4490-4. PubMed ID: 22615278
    [Abstract] [Full Text] [Related]

  • 26. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.
    Holmes AR, Tsao S, Ong SW, Lamping E, Niimi K, Monk BC, Niimi M, Kaneko A, Holland BR, Schmid J, Cannon RD.
    Mol Microbiol; 2006 Oct; 62(1):170-86. PubMed ID: 16942600
    [Abstract] [Full Text] [Related]

  • 27. Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans.
    Schubert S, Barker KS, Znaidi S, Schneider S, Dierolf F, Dunkel N, Aïd M, Boucher G, Rogers PD, Raymond M, Morschhäuser J.
    Antimicrob Agents Chemother; 2011 May; 55(5):2212-23. PubMed ID: 21402859
    [Abstract] [Full Text] [Related]

  • 28. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
    Pourakbari B, Teymuri M, Mahmoudi S, Valian SK, Movahedi Z, Eshaghi H, Mamishi S.
    Infect Disord Drug Targets; 2017 May; 17(3):178-184. PubMed ID: 28558643
    [Abstract] [Full Text] [Related]

  • 29. cis-Acting elements within the Candida albicans ERG11 promoter mediate the azole response through transcription factor Upc2p.
    Oliver BG, Song JL, Choiniere JH, White TC.
    Eukaryot Cell; 2007 Dec; 6(12):2231-9. PubMed ID: 17951521
    [Abstract] [Full Text] [Related]

  • 30. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.
    Henry KW, Cruz MC, Katiyar SK, Edlind TD.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1968-74. PubMed ID: 10428921
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance.
    Liu Z, Myers LC.
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807921
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ, Kasai M, Francesconi A, Landsman D, Chanock SJ.
    J Med Vet Mycol; 1997 Nov; 35(2):133-7. PubMed ID: 9147273
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. MDR1-mediated drug resistance in Candida dubliniensis.
    Wirsching S, Moran GP, Sullivan DJ, Coleman DC, Morschhäuser J.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3416-21. PubMed ID: 11709317
    [Abstract] [Full Text] [Related]

  • 39. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A.
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [Abstract] [Full Text] [Related]

  • 40. Expression of CDR1, a multidrug resistance gene of Candida albicans: transcriptional activation by heat shock, drugs and human steroid hormones.
    Krishnamurthy S, Gupta V, Prasad R, Panwar SL, Prasad R.
    FEMS Microbiol Lett; 1998 Mar 15; 160(2):191-7. PubMed ID: 9532737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.